Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE MultiStem Ischemic Stroke Study
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 34 - Athersys Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Athersys Inc Today - Breaking & Trending Today
Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE Multistem Ischemic Stroke Study
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Athersys (NASDAQ:ATHX) Raised to "Hold" at Zacks Investment Research
Athersys (NASDAQ:ATHX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs […]
Source: etfdailynews.com
$83 Bn Regenerative Medicine Markets - Global Opportunity Analysis and Industry Forecast, 2021-2022
DUBLIN--(BUSINESS WIRE)--The "Regenerative Medicine Market by Product Type, Material, Application and End user (Hospitals, Ambulatory Surgical Centers, and Others: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.The regenerative medicine market...
Source: pharmiweb.com
Athersys Stock: Focus On Stroke (NASDAQ:ATHX)
Athersys has been focused on developing a viable treatment for stroke for nearly 20 years. Read more to find out if now a good time to buy ATHX stock.
Source: seekingalpha.com